retatrutide patent expiration The upcoming expiry of the semaglutide in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Semaglutide & Tirzepatide Patent Considerations

This underscores the importance of full transparency with AMEs

Before After At the age of 60, I look and feel better than I ever have in my entire life

Mar 18, 2026 Articles, Cardiology, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 805 views Why do some patients still face heart risks even after managing blood sugar and cholesterol

MllerTDFinanBClemmensenCDiMarchiRDTschpMH

Divis Laboratories made the most interesting choice here

Those with overweight or obesity tend also to have more joint pain and decreased mobility. Even modest weight loss with RA can sometimes improve joint pain, mobility, and treatment response